Sort   by:  
 Page size 
UnknownUtility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.
Not available
S-EPMC4322260 | biostudies-literature
UnknownMethotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Not available
S-EPMC3948096 | biostudies-literature
UnknownPhase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies.
Not available
S-EPMC8710083 | biostudies-literature
UnknownArtemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.
Not available
S-EPMC10111164 | biostudies-literature
UnknownIbrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy.
Not available
S-EPMC7387295 | biostudies-literature
TranscriptomicsTranscription profiling of human ALL - 35 patients at diagnosis and relapse
35 paired samples from initial diagnosis and first marrow relapse. Genes and pathways differentiating diagnosis and relapse were identified. Potential therapeutic targets were also identified. Experiment Overall Design: 35 patients with samples from initial diagnosis and first marrow relapse.
ORGANISM(S): Homo sapiens 
2008-06-12 | E-GEOD-3910 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human ALL patients, first bone marrow relapse with or without initial diagnosis
This SuperSeries comprises the following subset Series:; GSE3910: 35 patients at diagnosis and relapse; GSE3911: 60 samples obtained at relapse Experiment Overall Design: Refer to individual Series
ORGANISM(S): Homo sapiens 
2008-06-12 | E-GEOD-3912 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human ALL patients with first bone marrow relapse
Gene expression profiles were analyzed from 60 children with first bone marrow relapse. Genes and pathways differentiating early vs. late relapse were identified. Signatures predicting early response to therapy were also identified. Experiment Overall Design: 60 patients at relapse were analyzed
ORGANISM(S): Homo sapiens 
2008-06-13 | E-GEOD-3911 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia
The cure rate for childhood ALL has improved considerably in part because therapy is routinely tailored to the predicted risk of relapse. Various clinical and laboratory variables are used in current risk-stratification schemes, but many children who fail therapy lack adverse prognostic factors at i...
ORGANISM(S): Homo sapiens 
2008-06-15 | E-GEOD-7440 | biostudies-arrayexpress
UnknownAntibody-Drug Conjugates for the Treatment of Acute Pediatric Leukemia.
Not available
S-EPMC8396964 | biostudies-literature
Sort   by:  
 Page size